bf/NYSE:TEVA_icon.png

COM:TEVAPHARM

Teva Pharmaceutical Industries Ltd.

  • Stock

USD

Last Close

17.08

22/11 21:00

Market Cap

19.23B

Beta: -

Volume Today

6.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.28B
-
4.71B
10.72%
4.17B
11.53%
4.46B
6.99%
4.94B
10.74%
4.83B
2.26%
4.58B
5.20%
4.41B
3.58%
4.11B
6.84%
3.83B
6.93%
average payables
7.16B
-
7.59B
6.00%
8.74B
15.21%
5.81B
33.57%
2.11B
63.62%
1.96B
7.19%
1.79B
8.95%
1.74B
2.72%
1.72B
0.92%
1.79B
3.81%
average receivables
5.46B
-
5.37B
1.50%
5.38B
0.11%
6.44B
19.66%
7.33B
13.81%
6.47B
11.61%
5.75B
11.21%
5.13B
10.79%
4.55B
11.18%
4.11B
9.71%
book value per share
26.58
-
27.33
2.83%
34.82
27.39%
34.91
0.26%
17.09
51.06%
14.40
15.69%
12.81
11.09%
9.16
28.50%
9.33
1.86%
7.11
23.72%
capex per share
-1.21
-
-1.09
10.32%
-0.90
17.09%
-0.94
4.49%
-0.86
8.82%
-0.64
25.88%
-0.11
82.89%
-0.53
383.94%
-0.51
3.39%
-0.49
3.19%
-0.47
4.79%
capex to depreciation
-0.63
-
-0.62
1.89%
-0.59
4.19%
-0.59
0.17%
-0.41
30.00%
-0.35
14.60%
-0.29
19.06%
-0.37
29.77%
-0.42
13.83%
-0.42
0.85%
-0.46
8.89%
capex to operating cash flow
-0.32
-
-0.18
43.11%
-0.14
23.12%
-0.17
23.79%
-0.25
44.52%
-0.27
6.79%
-0.22
16.89%
-0.48
114.90%
-0.70
48.16%
-0.34
51.06%
-0.38
11.56%
capex to revenue
-0.05
-
-0.05
9.71%
-0.04
14.28%
-0.04
4.72%
-0.04
5.09%
-0.03
11.57%
-0.01
79.59%
-0.03
392.39%
-0.04
2.01%
-0.04
3.74%
-0.03
9.59%
cash per share
1.22
-
2.61
113.45%
8.12
211.31%
1.03
87.27%
0.95
8.38%
1.75
84.14%
1.81
3.72%
1.99
9.83%
1.96
1.18%
2.52
28.44%
days of inventory on hand
191.98
-
173.11
9.83%
174.49
0.80%
180.03
3.17%
155.47
13.64%
163.56
5.20%
172.61
5.53%
179.91
4.23%
168.22
6.49%
175.94
4.58%
days payables outstanding
271.69
-
317.91
17.01%
416.21
30.92%
78.39
81.17%
65.33
16.66%
64.06
1.94%
67.06
4.68%
71.75
6.99%
74.29
3.54%
86.61
16.59%
days sales outstanding
95.91
-
97.37
1.52%
99.37
2.05%
125.37
26.17%
116.23
7.29%
112.71
3.03%
122.68
8.85%
100.38
18.18%
104.11
3.72%
90.39
13.18%
debt to assets
0.26
-
0.22
13.30%
0.18
17.42%
0.39
109.78%
0.46
19.33%
0.48
3.61%
0.48
0.16%
0.52
9.57%
0.49
5.59%
0.49
0.45%
debt to equity
0.54
-
0.44
18.01%
0.33
24.41%
1.07
220.71%
1.87
74.21%
1.97
5.10%
1.96
0.47%
2.63
34.55%
2.28
13.31%
2.73
19.62%
dividend yield
0.03
-
0.02
26.37%
0.02
12.67%
0.05
118.68%
0.06
33.99%
0.00
97.68%
0.00
248.05%
earnings yield
0.04
-
0.06
66.99%
0.03
54.56%
0.01
66.41%
-0.84
8,989.28%
-0.14
83.83%
-0.09
31.58%
-0.38
304.13%
0.05
112.51%
-0.23
592.02%
-0.05
79.41%
enterprise value
45.18B
-
57.16B
26.51%
59.14B
3.48%
69.43B
17.39%
50.77B
26.88%
42.88B
15.54%
36.06B
15.90%
34.79B
3.52%
30.12B
13.41%
28.88B
4.11%
enterprise value over ebitda
11.41
-
12.73
11.60%
11.57
9.15%
14.92
29.05%
9.78
34.46%
13.57
38.72%
11.22
17.29%
7.55
32.76%
6.65
11.85%
7.04
5.77%
ev to operating cash flow
13.96
-
11.15
20.13%
10.67
4.27%
13.29
24.51%
14.48
8.93%
17.53
21.10%
67.02
282.34%
28.61
57.32%
37.75
31.94%
18.17
51.87%
ev to sales
2.22
-
2.82
26.77%
3.01
6.74%
3.17
5.33%
2.27
28.46%
2.27
0.28%
2.14
6.11%
2.09
2.20%
1.90
9.16%
1.94
2.01%
free cash flow per share
2.60
-
4.92
89.41%
5.58
13.36%
4.53
18.84%
2.59
42.76%
1.76
32.16%
0.38
78.16%
0.58
51.71%
0.21
63.24%
0.94
338.34%
0.75
19.84%
free cash flow yield
0.06
-
0.09
32.00%
0.08
0.68%
0.12
46.96%
0.14
9.49%
0.11
16.63%
0.04
65.63%
0.06
54.07%
0.03
55.72%
0.10
284.99%
0.07
29.98%
graham net net
-20.38
-
-17.11
16.04%
-13.32
22.16%
-51.09
283.52%
-42.42
16.97%
-35.63
16.01%
-31.13
12.62%
-29.01
6.82%
-26.27
9.44%
-25.07
4.58%
graham number
29.90
-
46.93
56.97%
38.14
18.72%
16.45
56.88%
78.45
376.91%
26.12
66.70%
16.24
37.82%
27.40
68.67%
8.91
67.48%
18.42
106.72%
income quality
2.58
-
1.69
34.76%
3.47
105.90%
16.80
384.13%
-0.21
101.27%
-0.99
364.10%
7.08
815.42%
-0.30
104.19%
1.75
689.91%
-0.66
137.76%
-2.22
236.60%
intangibles to total assets
0.54
-
0.52
3.84%
0.49
4.50%
0.71
44.16%
0.65
8.07%
0.64
1.65%
0.63
2.12%
0.58
7.06%
0.58
1.10%
0.54
5.87%
0
100%
interest coverage
4.13
-
12.62
205.43%
3.35
73.45%
1.62
51.68%
-19.54
1,306.21%
-1.71
91.26%
3.40
299.34%
3.17
6.83%
3.02
4.66%
2.90
4.21%
interest debt per share
14.83
-
12.47
15.88%
12.83
2.84%
38.88
203.08%
32.84
15.52%
29.26
10.91%
25.81
11.78%
24.99
3.21%
22.25
10.96%
20.29
8.78%
inventory turnover
1.90
-
2.11
10.90%
2.09
0.79%
2.03
3.08%
2.35
15.79%
2.23
4.94%
2.11
5.24%
2.03
4.06%
2.17
6.94%
2.07
4.38%
invested capital
0.54
-
0.44
18.01%
0.33
24.41%
1.07
220.71%
1.87
74.21%
1.97
5.10%
1.96
0.47%
2.63
34.55%
2.28
13.31%
2.73
19.62%
market cap
34.03B
-
49.06B
44.16%
56.12B
14.40%
34.62B
38.32%
19.25B
44.39%
15.74B
18.23%
10.69B
32.09%
10.57B
1.17%
8.83B
16.46%
10.12B
14.68%
11.68B
15.40%
net current asset value
-11.15B
-
-8.67B
22.27%
-5.93B
31.56%
-40.94B
589.97%
-36.49B
10.87%
-31.09B
14.78%
-28.94B
6.92%
-26.57B
8.19%
-23.85B
10.25%
-23.26B
2.45%
net debt to ebitda
2.82
-
1.80
35.92%
0.59
67.25%
7.48
1,166.36%
6.07
18.86%
8.59
41.42%
7.90
8.05%
5.25
33.45%
4.70
10.49%
4.57
2.82%
net income per share
1.49
-
3.58
139.61%
1.86
48.14%
0.34
81.45%
-16.01
4,746.95%
-2.11
86.85%
-0.92
56.52%
-3.64
297.94%
0.38
110.38%
-2.12
660.20%
-0.50
76.43%
operating cash flow per share
3.81
-
6.01
57.64%
6.48
7.84%
5.47
15.59%
3.45
36.91%
2.40
30.60%
0.49
79.42%
1.11
125.20%
0.72
34.79%
1.43
97.81%
1.22
14.65%
payables turnover
1.34
-
1.15
14.54%
0.88
23.62%
4.66
430.98%
5.59
19.99%
5.70
1.98%
5.44
4.47%
5.09
6.54%
4.91
3.41%
4.21
14.23%
receivables turnover
3.81
-
3.75
1.50%
3.67
2.01%
2.91
20.74%
3.14
7.86%
3.24
3.12%
2.98
8.13%
3.64
22.22%
3.51
3.59%
4.04
15.18%
research and ddevelopement to revenue
0.07
-
0.07
4.49%
0.08
5.72%
0.10
24.20%
0.08
14.34%
0.06
22.07%
0.06
7.04%
0.06
0.07%
0.06
1.76%
0.06
7.81%
0.06
7.11%
return on tangible assets
0.06
-
0.14
135.94%
0.06
57.56%
0.01
78.85%
-0.66
5,533.50%
-0.10
85.08%
-0.05
52.73%
-0.19
305.06%
0.02
110.93%
-0.12
665.87%
revenue per share
23.93
-
23.77
0.67%
22.98
3.29%
22.94
0.22%
22.03
3.94%
18.47
16.19%
15.48
16.18%
15.21
1.72%
14.41
5.29%
13.45
6.68%
14.16
5.32%
roe
0.06
-
0.13
133.02%
0.05
59.29%
0.01
81.50%
-0.94
9,594.24%
-0.15
84.40%
-0.07
51.09%
-0.40
456.59%
0.04
110.19%
-0.30
834.40%
roic
0.05
-
0.10
100.44%
0.06
37.36%
0.01
81.41%
-0.31
2,840.33%
-0.03
88.94%
0.05
250.61%
0.08
52.23%
0.06
20.06%
0.07
16.81%
sales general and administrative to revenue
0.06
-
0.06
1.57%
0.06
5.02%
0.06
10.49%
0.06
5.29%
0.07
15.87%
0.07
2.53%
0.07
0.24%
0.07
1.71%
0.08
14.23%
0.07
7.25%
shareholders equity per share
26.58
-
27.33
2.83%
34.82
27.39%
34.91
0.26%
17.09
51.06%
14.40
15.69%
12.81
11.09%
9.16
28.50%
9.33
1.86%
7.11
23.72%
stock based compensation to revenue
0.00
-
0.00
48.75%
0.01
27.04%
0.01
4.91%
0.01
4.95%
0.01
38.37%
0.00
85.59%
0.01
553.87%
0.01
3.22%
0.01
10.86%
0.01
8.09%
tangible asset value
-2.82B
-
-565M
79.97%
3.23B
671.15%
-30.90B
1,057.64%
-27.31B
11.63%
-23.13B
15.31%
-21.02B
9.14%
-18.49B
12.03%
-16.26B
12.03%
-15.21B
6.46%
tangible book value per share
-3.32
-
-0.66
80.07%
3.77
669.81%
-32.36
957.36%
-26.88
16.94%
-22.65
15.72%
-19.26
14.97%
-16.88
12.36%
-14.76
12.59%
-13.70
7.13%
working capital
1.75B
-
2.11B
20.06%
5.39B
155.96%
-1.56B
128.89%
-2.54B
62.97%
-528M
79.20%
-210M
60.23%
-159M
24.29%
1.55B
1,072.33%
582M
62.35%

All numbers in USD (except ratios and percentages)